Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) (RXR)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06023459 |
|
Recruitment Status :
Not yet recruiting
First Posted : September 5, 2023
Last Update Posted : April 29, 2024
|
Sponsor:
Yih-Ing Hser
Collaborators:
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
The Emmes Company, LLC
University of California, Los Angeles
RAND
Cornell University
Oregon Health and Science University
University of Illinois at Chicago
University of Washington
West Virginia University
Information provided by (Responsible Party):
Yih-Ing Hser, University of California, Los Angeles
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | November 30, 2024 |
| Estimated Study Completion Date : | December 30, 2024 |